Graeme Irvine Stevenson
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Graeme Irvine Stevenson.
Bioorganic & Medicinal Chemistry Letters | 2000
Graeme Irvine Stevenson; Adrian Leonard Smith; Stephen John Lewis; Stephen G Michie; Joseph George Neduvelil; Smita Patel; Rosemarie Marwood; Shil Patel; José L. Castro
A series of 2-aryl tryptamines have been identified as high-affinity h5-HT2A antagonists. Structure-activity relationship studies have shown that h5-HT2A affinity can be attained via modifications to the tryptamine side chain and that selectivity over h5-HT2C and hD2 receptors can be controlled by suitable C-2 aryl groups.
Tetrahedron Letters | 1998
Adrian Leonard Smith; Graeme Irvine Stevenson; Christopher John Swain; JoséL. Castro
Abstract An efficient method for the traceless solid phase synthesis of 2,3-disubstituted indoles using a THP linker and a Pd(0)-mediated annulation of 2-iodoaniline and acetylenes is reported.
Bioorganic & Medicinal Chemistry Letters | 2000
Adrian Leonard Smith; Graeme Irvine Stevenson; Stephen John Lewis; Smita Patel; Jose L. Castro
The application of a novel solid-phase synthesis of 2,3-disubstituted indoles utilizing a carbamate indole linker is described resulting in the identification of the novel, high-affinity, selective h5-HT2A antagonist 19.
Bioorganic & Medicinal Chemistry Letters | 1993
Paul D. Leeson; Raymond Baker; Robert W. Carling; Janusz Jozef Kulagowski; Ian M. Mawer; Mark Peter Ridgill; Michael Rowley; Julian D. Smith; Ian Stansfield; Graeme Irvine Stevenson; Alan C. Foster; John A. Kemp
Abstract 3-Substituted-2-quinoloners ( 6–8 ) have been identified as glycine-site N-methyl-D-aspartate receptor antagonists. It is proposed that the α-phenyl lactam unit in the potent 4-hydroxy-3-phenyl derivatives ( 7d and 8b , L-701,315) may act as a glycine bioisostere in receptor recognition.
Bioorganic & Medicinal Chemistry Letters | 1998
Jason Matthew Elliott; Howard B. Broughton; Margaret A. Cascieri; Gary G. Chicchi; Ian Thomas Huscroft; Marc M. Kurtz; Angus Murray Macleod; Sharon Sadowski; Graeme Irvine Stevenson
Modifications to the spirocyclic aryl sulfonamide portion of serine derived NK1 antagonists allow a partial pharmacophore model to be developed.
Bioorganic & Medicinal Chemistry Letters | 1998
Jason Matthew Elliott; Margaret A. Cascieri; Gary G. Chicchi; S. Davies; Fintan Kelleher; Marc M. Kurtz; Tammy Ladduwahetty; Richard Thomas Lewis; Angus Murray Macleod; Kevin John Merchant; Sharon Sadowski; Graeme Irvine Stevenson
A series of novel serine derived NK1 antagonists is described. The effect of variations in the N-benzyl, O-benzyl and serine groups are used to define the elements which are necessary for binding.
Bioorganic & Medicinal Chemistry Letters | 1992
Graeme Irvine Stevenson; Paul D. Leeson; Michael Rowley; Ian Sanderson; Ian Stansfield
N-Arylimino esters (3) react with enamides (4) under Lewis acid catalysis to afford cis 4-amido-2-carboxytetrahydroquinolines (5). The products of this reaction are easily converted to the biologically active trans conformers. Introduction of substituents at C-3 has no effect on affinity at the Glycine site of the NMDA receptor.
Journal of Medicinal Chemistry | 1992
Paul D. Leeson; Robert W. Carling; Kevin William Moore; Moseley Am; Julian D. Smith; Graeme Irvine Stevenson; Chan T; Baker R; Alan C. Foster; Sarah Grimwood
Archive | 2001
Alan John Nadin; Graeme Irvine Stevenson
Journal of Medicinal Chemistry | 1997
Michael Rowley; Janusz Jozef Kulagowski; Alan P. Watt; Denise Rathbone; Graeme Irvine Stevenson; Robert W. Carling; Raymond Baker; George R. Marshall; John A. Kemp; Alan C. Foster; Sarah Grimwood; Richard Hargreaves; Catherine Hurley; Kay L. Saywell; Mark Tricklebank; Paul D. Leeson